Retroviral WASP gene transfer into human hematopoietic stem cells reconstitutes the actin cytoskeleton in myeloid progeny cells differentiated in vitro.
暂无分享,去创建一个
U. Pannicke | K. Schwarz | M. Ballmaier | C. Klein | S. Snapper | K. Welte | A. Filipovich | J. Greil | T. Güngör | A. Maschan | C. Happel | R. Dewey | F. Noyan | I. Avedillo Díez
[1] F. Alt,et al. WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo , 2005, Journal of leukocyte biology.
[2] P. Opolon,et al. A lentiviral vector encoding the human Wiskott–Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice , 2005, Gene Therapy.
[3] C. Frecha,et al. Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences , 2005, Gene Therapy.
[4] W. Vainchenker,et al. Mechanisms of WASp-mediated hematologic and immunologic disease. , 2004, Blood.
[5] T. Laín de Lera,et al. Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[6] P. Doherty,et al. Defects in T-cell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells. , 2003, Blood.
[7] E. Haddad,et al. A defect in hematopoietic stem cell migration explains the nonrandom X-chromosome inactivation in carriers of Wiskott-Aldrich syndrome. , 2003, Blood.
[8] A. Nienhuis,et al. Functional correction of T cells derived from patients with the Wiskott–Aldrich syndrome (WAS) by transduction with an oncoretroviral vector encoding the WAS protein , 2003, Gene Therapy.
[9] F. Alt,et al. Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice. , 2003, Blood.
[10] Christof von Kalle,et al. Side effects of retroviral gene transfer into hematopoietic stem cells. , 2003, Blood.
[11] Adrian J. Thrasher,et al. Wasp in immune-system organization and function , 2002, Nature Reviews Immunology.
[12] Yasuhiko Ito,et al. Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation: evaluation by flow cytometric analysis of intracellular WAS protein expression. , 2002, Blood.
[13] G. Dunn,et al. Restoration of podosomes and chemotaxis in Wiskott-Aldrich syndrome macrophages following induced expression of WASp. , 2002, The international journal of biochemistry & cell biology.
[14] F. Candotti,et al. Retrovirus-mediated WASP gene transfer corrects Wiskott-Aldrich syndrome T-cell dysfunction. , 2002, Human gene therapy.
[15] Sheila M. Thomas,et al. N-WASP deficiency reveals distinct pathways for cell surface projections and microbial actin-based motility , 2001, Nature Cell Biology.
[16] G. E. Jones,et al. Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation. , 2001, Blood.
[17] J. V. Stone,et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. , 2001, Blood.
[18] C. Klein,et al. Comparative Analysis of Genetically Modified Dendritic Cells and Tumor Cells as Therapeutic Cancer Vaccines , 2000, The Journal of experimental medicine.
[19] C Kinnon,et al. Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis. , 2000, Blood.
[20] S. Tsuboi,et al. Expression of human Wiskott–Aldrich syndrome protein in patients’ cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins , 2000, Gene Therapy.
[21] M. Aepfelbacher,et al. Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[22] F. Facchetti,et al. Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott–Aldrich syndrome patients carrying ‘null’ mutations , 1999, Gene Therapy.
[23] R. Mulligan,et al. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[24] A. Fischer,et al. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center. , 1996, The Journal of pediatrics.
[25] J. James. A MULTI-INSTITUTIONAL SURVEY OF THE WISKOTT-ALDRICH SYNDROME , 1996, Pediatrics.
[26] U. Francke,et al. Wiskott–Aldrich Syndrome Protein, a Novel Effector for the GTPase CDC42Hs, Is Implicated in Actin Polymerization , 1996, Cell.
[27] F. Rosen,et al. Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome. , 1995, Blood.
[28] K. Sullivan,et al. A multiinstitutional survey of the Wiskott-Aldrich syndrome. , 1994, The Journal of pediatrics.
[29] U. Francke,et al. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome , 1994, Cell.
[30] J. Belli,et al. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. , 1978, The New England journal of medicine.
[31] L. Notarangelo,et al. Primary immunodeficiency diseases , 2008 .
[32] H. Ochs. The Wiskott-Aldrich syndrome , 1998, Springer Seminars in Immunopathology.